Prognostic factors in prostate cancer

Area of Science:

• Urology
• Pathology
• Molecular Oncology

Background:

• Prognostic factors are crucial for predicting prostate cancer (PCa) outcomes.
• Accurate prediction aids treatment decisions for urologists, pathologists, and patients.
• Traditional factors have limitations in predicting PCa behavior.

Purpose of the Study:

• To review traditional and novel molecular prognostic factors for prostate cancer.
• To assess the clinical utility of established and emerging PCa biomarkers.
• To provide an overview of validated and investigational prognostic markers.

Main Methods:

• Literature review of traditional and molecular prognostic factors in prostate cancer.
• Analysis of factors used in clinical practice and those under investigation.
• Synthesis of data on the predictive accuracy of various prognostic markers.

Main Results:

• Several traditional and molecular factors show promise in predicting PCa outcomes.
• Widespread clinical use varies among prognostic tests.
• Emerging molecular markers require further validation in clinical trials.

Conclusions:

• A range of prognostic factors, both traditional and molecular, are available for prostate cancer.
• The selection of prognostic factors depends on clinical validation and utility.
• Continued research is needed to validate emerging molecular markers for PCa management.